NBSE - NEUBASE THERAPEUTICS INC
This page shows which of the focused investors we track hold NBSE and how their positions changed, so you can see how much conviction the group has in the stock.
In Q1 2023 it was held by 1 manager with an aggregate reported value of $504.5K, which is 0.00% of the combined portfolio.
As of Q1 2023, 1 tracked institutional manager held NBSE (NEUBASE THERAPEUTICS INC) with an aggregate reported value of $504.5K — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades NBSE — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q1 2023
- Ticker
- NBSE
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | David Einhorn - Greenlight Capital | 0.03% | - | 2,727,027 | $504.5K |
Loading holder history for NBSE…